Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06232317
Other study ID # PRO00037724
Secondary ID R03AG078857
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date December 9, 2023
Est. completion date December 31, 2024

Study information

Verified date January 2024
Source The Methodist Hospital Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to assess the feasibility, acceptability, and safety of using ReCognitionVR virtual reality-based software in older surgical patients. Results from this study will be used to inform the design of a future study in critically ill hospitalized patients at risk for delirium.


Description:

Virtual reality (VR) imitates reality by creating an artificial 3-dimensional (3D) environment using computing technology or software. A virtual environment (VE) is created using this software with a headset, which cognitively stimulates the user's brain to think they are in an artificial world. Creating a VE allows flexibility and measurement of different types of stimuli while recording the various responses provided by users in the controlled VE. VR strengthens the brain's ability to focus, learn, and retain experience. VR for attention deficit disorders has been reported to have promising results. We followed in similar footsteps and designed and developed a novel, 3D simulated software platform prototype called ReCognition VR to provide VR-based cognitive exercises. A feasibility clinical trial conducted by our group tested the ReCognitionVR cognitive interventions on older and young healthy volunteers (NCT05583903). The results of this study showed that ReCognitionVR-based cognitive exercises were feasible, acceptable, and tolerable by older healthy subjects. In stage 2 of our research study, we want to evaluate the safety, feasibility, acceptability, and tolerability of VR-based cognitive exercises in 60-year-old or older patients following abdominal surgery admitted to the surgical floor at Houston Methodist Hospital (HMH). Our premise is that VR-based cognitive stimulation software will allow the controlled delivery of structured cognitive exercises focusing on orientation, attention, memory, and executive functions. The system will allow customized frequency and duration of cognitive exercises based on the users' difficulty level in a delightfully relaxed environment with beach wave sounds.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 30
Est. completion date December 31, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - =60 years of age - Scheduled to undergo the following abdominal surgeries (open or laparoscopic or robotic assisted): small bowel and large bowel surgery; cholecystectomy; Whipple procedure; pancreatectomy; splenectomy. - Richmond Agitation-Sedation Scale (RASS) Score 0 Exclusion Criteria: - Subjects with baseline cognitive impairment - Person with active psychiatric disorders and being treated with medications, especially schizophrenia - Person who is deaf or blind - Person with an underlying cognitive disorder or associated phobias (e.g., claustrophobia) - Person participating in other clinical trials involving drugs, biologics, devices, or behavioral interventions - Active seizure disorders

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual Reality Software
The ReCognitionVR virtual reality software is delivered via an Oculus Quest 2 device. This three-dimensional simulated software was designed to improve attention and executive functions.
Traditional Orientation Methods
Standard-of-care methods to orient patients after surgery

Locations

Country Name City State
United States Houston Methodist Research Institute Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
The Methodist Hospital Research Institute National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Percentage of Participants Using Virtual Reality Software at 20 Minutes after Start For participants in the experimental (virtual reality) arm, Whether 70% of participants in each group will complete 20 minutes of use of the ReCognition VR-based software (a binary outcome) 20 minutes after the start of software use
Other Participants With a System Usability Scale Score >35 For participants in the experimental (virtual reality) arm, the proportion of participants with a System Usability Scale score >35 on a scale of 0-100, where higher scores mean better usability. After completion of use of the virtual reality software, up to 2 hours after the start of software use
Other Proportion of Participants Completing Game with No Errors The proportion of participants in the experimental (virtual reality) arm who complete the virtual reality game without any user errors After completion of use of the virtual reality software, up to 2 hours after the start of software use
Other Number of Attempts to Complete the Game For participants in the experimental (virtual reality) arm, the number of attempts a participant takes to complete the virtual reality game After completion of use of the virtual reality software, up to 2 hours after the start of software use
Other Number of Software and Device Restarts For participants in the experimental (virtual reality) arm, the number of times the virtual reality device needed to be restarted during game play After completion of use of the virtual reality software, up to 2 hours after the start of software use
Other Number of Software and Device Resets For participants in the experimental (virtual reality) arm, the number of times the virtual reality device needed to be reset during game play After completion of use of the virtual reality software, up to 2 hours after the start of software use
Primary Proportion of treatment-emergent adverse events (TEAE) Proportion of participants who experience a treatment-emergent adverse event Within 1 month of enrolling in the study
Secondary Change From Baseline in Pulse Oximetry Oxygen Saturation after 10 Minutes Pulse oximetry oxygen saturation measured using a vital sign monitor at baseline (immediately prior to intervention [VR software or traditional orientation methods]) and 10 minutes after intervention. Change = 10-minute oxygen saturation - baseline oxygen saturation Baseline and 10 minutes
Secondary Change from baseline in respiratory rate after 10 minutes Respiratory rate at baseline (immediately prior to intervention [VR software or traditional orientation methods]) and 10 minutes after intervention. Change = 10-minute respiratory rate - baseline respiratory rate Baseline and 10 minutes
Secondary Change from baseline in systolic blood pressure after 10 minutes Systolic blood pressure measured using a vital sign monitor at baseline (immediately prior to intervention [VR software or traditional orientation methods]) and 10 minutes after intervention. Change = 10-minute systolic blood pressure - baseline systolic blood pressure Baseline and 10 minutes
Secondary Change from baseline in diastolic blood pressure after 10 minutes Diastolic blood pressure measured using a vital sign monitor at baseline (immediately prior to intervention [VR software or traditional orientation methods]) and 10 minutes after intervention. Change = 10-minute diastolic blood pressure - baseline diastolic blood pressure Baseline and 10 minutes
Secondary Change from baseline in pulse oximetry oxygen saturation after completion Pulse oximetry oxygen saturation measured using a vital sign monitor at baseline (immediately prior to intervention [VR software or traditional orientation methods]) and after completion of intervention. Change = completion oxygen saturation - baseline oxygen saturation Baseline and completion of the intervention, up to 2 hours
Secondary Change from baseline in respiratory rate after completion Respiratory rate at baseline (immediately prior to intervention [VR software or traditional orientation methods]) and after completion of intervention. Change = completion respiratory rate - baseline respiratory rate Baseline and completion of the intervention, up to 2 hours
Secondary Change from baseline in systolic blood pressure after completion Systolic blood pressure measured using a vital sign monitor at baseline (immediately prior to intervention [VR software or traditional orientation methods]) and after completion of intervention. Change = completion systolic blood pressure - baseline systolic blood pressure Baseline and completion of the intervention, up to 2 hours
Secondary Change from baseline in diastolic blood pressure after completion Diastolic blood pressure measured using a vital sign monitor at baseline (immediately prior to intervention [VR software or traditional orientation methods]) and after completion of intervention. Change = completion diastolic blood pressure - baseline diastolic blood pressure Baseline and completion of the intervention, up to 2 hours
Secondary Positive Confusion Assessment Method and/or 4 A's Test The proportion of patients who have a positive Confusion Assessment Method (CAM) or 4 A's Test for delirium Baseline, 24 hours, 48 hours, 72 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A
Completed NCT03355547 - Observation of Atelectasis Using Lung Ultrasonography in Children Undergoing General Anesthesia: the Cohort Study for Evaluation of the Relationship Between the Incidence and Severity of Upper Respiratory Tract Infection and the Magnitude of Anesthesia-induced Atelectasis